Earlier in 2026, IDEXX Laboratories integrated SDMA, a key renal biomarker recognized by the International Renal Interest ...
IDEXX integrates SDMA into most common Catalyst chemistry profiles, enabling earlier detection of kidney disease through routine in‑clinic testing.
With school out for summer, parents all over Southern California are seeking enriching and fun activities to keep their kids engaged. The San Diego Museum of Art is the perfect destination, offering a ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into Catalyst™ CLIPs, making complete kidney function ...